In brief: Crossbeta’s Technology & Main Applications

Many factors contribute to protein misfolding and protein misfolding diseases. The ‘crossbeta pathway’ facilitates adequate removal of obsolete proteins preventing their pathological accumulation.

Modulation of the crossbeta pathway provides a unique manner to develop therapeutics to conquer a wide variety of diseases, such as Alzheimer’s disease and other amylodosis. Based on the crossbeta pathway Crossbeta Biosciences develops dedicated disease modifying treatments for these unmet medical needs.

Crossbeta also provides a means to boost the immunogenicity of safe, purified antigen vaccines devoid of chemical adjuvants.